Frank Greenway, M.D.Professor--Chief Medical Officer
Clinical Medical Doctor-Greenway
Pharmacology-based Clinical Trials
EDUCATIONM.D., University of California, Los Angeles, CA, 1970
RESEARCH INTERESTSDr. Greenway's area of interest is developing obesity treatments including diets, herbal supplements, medical foods, devices, obesity surgery and obesity drug development. He directs the outpatient research clinic.
SELECTED PUBLICATIONSZheng J, Sonnier T, Vase A, Korivi N, Ajmera P, Morrison SF, DiLorenzo DJ, Greenwa FL. A less invasive surgical approach for splanchnic nerve stimulation to treat obesity. Obes Surg 2012;22((11):1783-4.
Liu AG, Most MM, Brashear MM, Johnson WD, Cefalu WT, Greenway FL. Reducing the glycemic index or carbohydrate content of mixed meals reduces posprandial glycemia and insulinemia over the entire day but does not affect satiety. Diabetes Care. 2012;35(8):1633-7.
Greenway F, Liu Z, Yu Y, Gupta A. A clinical trial testing the safety and efficacy of a standardized Eucommia ulmoides Oliver bark extract to treat hypertension. Altern Med Rev. 2011;16(4):338-47.
Twiner EM, Liu Z, Gimble J, Yu Y, Greenway F. Pharmacokinetic pilot study of the antiangiogenic activity of standardized platycodi radix. Adv Ther. 2011;28(10):857-65.
Plaisance EP, Greenway FL, Boudreau A, Hill KL, Johnson WD, Krajcik RA, Perrone CE, Orentreich N, Cefalu WT, Gettys TW. Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome. J Clin Endocrinol Metab. 2011;96(5):E836-40.
Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C; Endocrine Society. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(11):4823-43.
Greenway FL, Fujioka K, Plodkowski RA, Mudalair S, Guttadauria M, Erickson J, Kim DD, Dunayevich E; COR-1 Study Group. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-1): a multicenere, randomized, double-blind, placebo-controlled, phase III trial. Lancet 2010;376(9741):595-605.